Vertex Pharmaceuticals, Inc.

( )
VRTX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
JNJJohnson & Johnson -0.31%165.950.7%$1319.81m
LLYEli Lilly & Co. -0.46%332.611.1%$1037.91m
PFEPfizer Inc. -0.28%44.270.9%$799.00m
BMYBristol-Myers Squibb Co. 0.00%72.061.0%$784.71m
ABBVAbbVie, Inc. -0.18%144.301.9%$780.31m
MRKMerck & Co., Inc. -0.50%86.360.7%$699.47m
AZNAstraZeneca Plc 0.00%54.691.0%$437.06m
NVSNovartis AG -1.43%75.220.2%$218.10m
ALNYAlnylam Pharmaceuticals, Inc. 0.00%210.768.2%$210.83m
GSKGSK Plc -0.53%29.300.3%$204.95m
GBTGlobal Blood Therapeutics, Inc. 0.00%68.115.4%$190.67m
NVONovo Nordisk A/S 1.46%100.830.1%$178.16m
HZNPHorizon Therapeutics Plc -0.55%63.495.4%$169.03m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. 0.13%152.140.0%$158.36m
SGENSeagen Inc. 0.00%137.725.7%$129.81m

Company Profile

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.